Study Findings from Humanitas Clinical and Research Center Provide New Insights into Prostate Cancer (Radiomics-based Prognosis Classification for High-risk Prostate Cancer Treated With Radiotherapy).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      Keywords: Rozzano; Italy; Europe; Cancer; Drugs and Therapies; Health and Medicine; Hemic and Immune Systems; Immunology; Lymph Nodes; Lymphoid Tissue; Oncology; Prostate Cancer; Prostatic Neoplasms; Radiotherapy; Risk and Prevention EN Rozzano Italy Europe Cancer Drugs and Therapies Health and Medicine Hemic and Immune Systems Immunology Lymph Nodes Lymphoid Tissue Oncology Prostate Cancer Prostatic Neoplasms Radiotherapy Risk and Prevention 1469 1469 1 10/30/23 20231103 NES 231103 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Oncology - Prostate Cancer. For more information on this research see: Radiomics-based Prognosis Classification for High-risk Prostate Cancer Treated With Radiotherapy. [Extracted from the article]
    • Abstract:
      Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)